Logistics Companies Invest in Cold Chain Infrastructure to Meet Rising Healthcare Demand
As demand for temperature-sensitive pharmaceuticals like GLP-1 weight loss drugs surges, logistics companies such as UPS and FedEx are expanding their cold chain capabilities. These firms are investing millions into specialized facilities to ensure the safe transport of biologics that require refrigeration during shipping. The growth in obesity treatments has highlighted a broader trend: healthcare is becoming one of the fastest-growing segments for logistics providers. UPS recently announced a $48 million investment aimed at enhancing its temperature-controlled infrastructure, reflecting increased demand from pharmaceutical companies and patients alike. According to market reports, the global biologics shipping sector could reach nearly $39 billion by 2033 due to rising healthcare innovation.
Topics: FedEx GLP-1 drugs healthcare pharmaceuticals UPS